Cell Reprogramming Market Size, Share & Trends Analysis Report By Technology (Sendai Virus-based, mRNA Reprogramming), By Application (Research, Therapeutic), By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Cell Reprogramming Market Growth & Trends
The global cell reprogramming market size is expected to reach USD 625.92 million by 2030, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Cell reprogramming is known for its capacity to replace damaged cells or tissues, thereby reversing the negative physiological effects it causes. The industry is driven by the growing interest among researchers in the field for the reason that it makes it possible to see and evaluate molecular biological mechanisms like differentiation, epigenetics, and chromatin in ways that were formerly impossibly complex. Furthermore, cellular reprogramming also has a substantial impact on diagnosing and addressing human diseases. Moreover, reprogramming technology is being created & improved; there have also been substantial ongoing advancements in related technologies like gene editing, creation of progenitor cells, & tissue engineering.
The pharmaceutical industry is projected to use the iPSC approach widely to generate effective cell sources, such as iPSC-derived functional cells, to enable drug screening and toxicity assessment. Thus, the growing use of iPSC across the world would propel the demand for cell reprogramming resulting in industry growth. The increase in clinical trials and the wide usage of stem cell therapies around the world are fueling the industry's expansion. Various academic institutions, biotech & pharmaceutical companies, and government agencies from different nations are focusing on efficient and quick methods for the detection of COVID-19. Mesenchymal stem cells are a safe and efficient method for treating COVID-19, according to a 2020 research article that was published in the academic journal Aging and Disease (2020).
In addition, the lack of efficient treatment for COVID-19 has sparked the attention of the healthcare industry on cell reprogramming technology. As a result, the usage of cell reprogramming technologies is projected to increase during the COVID-19 pandemic. Despite the fact that mesenchymal cells and iPSCs are used in cell reprogramming, there are still several challenges that prevent the market from expanding. The main causes for concern are people’s lack of knowledge about the available treatments and their dread of the unknown therapy. On the other hand, the industry is positioned for growth as a result of the widening pipeline of stem cell therapies, growing interest in customized treatments, and rising healthcare spending. Moreover, the lenient rules that govern stem cell reprogramming in India may play a significant role in luring more businesses to invest in, develop, and market innovative technologies, fueling the continued expansion.
Cell Reprogramming Market Report Highlights
Cell Reprogramming Market Growth & Trends
The global cell reprogramming market size is expected to reach USD 625.92 million by 2030, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Cell reprogramming is known for its capacity to replace damaged cells or tissues, thereby reversing the negative physiological effects it causes. The industry is driven by the growing interest among researchers in the field for the reason that it makes it possible to see and evaluate molecular biological mechanisms like differentiation, epigenetics, and chromatin in ways that were formerly impossibly complex. Furthermore, cellular reprogramming also has a substantial impact on diagnosing and addressing human diseases. Moreover, reprogramming technology is being created & improved; there have also been substantial ongoing advancements in related technologies like gene editing, creation of progenitor cells, & tissue engineering.
The pharmaceutical industry is projected to use the iPSC approach widely to generate effective cell sources, such as iPSC-derived functional cells, to enable drug screening and toxicity assessment. Thus, the growing use of iPSC across the world would propel the demand for cell reprogramming resulting in industry growth. The increase in clinical trials and the wide usage of stem cell therapies around the world are fueling the industry's expansion. Various academic institutions, biotech & pharmaceutical companies, and government agencies from different nations are focusing on efficient and quick methods for the detection of COVID-19. Mesenchymal stem cells are a safe and efficient method for treating COVID-19, according to a 2020 research article that was published in the academic journal Aging and Disease (2020).
In addition, the lack of efficient treatment for COVID-19 has sparked the attention of the healthcare industry on cell reprogramming technology. As a result, the usage of cell reprogramming technologies is projected to increase during the COVID-19 pandemic. Despite the fact that mesenchymal cells and iPSCs are used in cell reprogramming, there are still several challenges that prevent the market from expanding. The main causes for concern are people’s lack of knowledge about the available treatments and their dread of the unknown therapy. On the other hand, the industry is positioned for growth as a result of the widening pipeline of stem cell therapies, growing interest in customized treatments, and rising healthcare spending. Moreover, the lenient rules that govern stem cell reprogramming in India may play a significant role in luring more businesses to invest in, develop, and market innovative technologies, fueling the continued expansion.
Cell Reprogramming Market Report Highlights
- The mRNA technology segment accounted for the largest share in 2021 due to the increased requirement for easy-to-use technology that offers quick, secure, and effective results
- By application, the research segment dominated the global industry in 2021. This is attributed to a rise in the funding by governments as well as other private groups, which is propelling the growth
- The research & academic end-user institutes segment dominated the industry in 2021 due to the growing demand for personalized medicines and the cost-effective use of bio-drugs employing this technology
- North America led the global industry in 2021 due to the presence of high R&D investment, availability of technologically advanced healthcare research framework, and the development of cell reprogrammed products in the region
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise Market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL CELL REPROGRAMMING MARKET VARIABLES, TRENDS, & SCOPE
4.1 Cell Reprogramming Market lineage outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Growing Industry Focus On Cell Reprogramming
4.4.2 Increasing Adoption Of Cell Reprogramming In Cancer Research
4.4.3 Strong Focus Of Key Players On Collaborations And Partnerships To Spur Market Growth
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Ethical Concerns Related To Embryonic Stem Cells
4.5.2 Limited Awareness Regarding Treatment Options To Restrain Market Growth
4.6 Porter’s Five Forces Analysis
4.7 Pipeline Analysis
CHAPTER 5 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Global Cell Reprogramming Market: Technology Movement Analysis
5.2 Sendai Virus-based Reprogramming
5.2.1 Sendai Virus-Based Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 mRNA Reprogramming
5.3.1 mRNA Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Episomal Reprogramming
5.4.1 Episomal Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global Cell Reprogramming Market: Application Movement Analysis
6.2 Research
6.2.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Therapeutic
6.3.1 Therapeutic Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
7.1 Cell Reprogramming Market: End-user Movement Analysis
7.2 Research & Academic Institutes
7.2.1 Research & Academic Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Biotechnology & Pharmaceutical Companies
7.3.1 Biotechnology & Pharmaceutical Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Hospitals & Clinics
7.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Cell Reprogramming Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 India
8.4.5.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.7 Australia
8.4.7.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 ALLELE BIOTECHNOLOGY
9.3.1.1 Company Overview
9.3.1.2 Alere, Inc.
9.3.1.3 Financial Performance
9.3.1.4 Product Benchmarking
9.3.1.5 Strategic Initiatives
9.3.2 ALSTEM
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 APPLIED BIOLOGICAL MATERIALS
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 AXOL BIOSCIENCE
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 CREATIVE BIOARRAY
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 DEFINIGEN
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 FUJIFILM CELLULAR DYNAMICS
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 LONZA
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 MOGRIFY
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 REPROCELL
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 STEMNOVATE
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 THERMO FISHER SCIENTIFIC
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise Market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL CELL REPROGRAMMING MARKET VARIABLES, TRENDS, & SCOPE
4.1 Cell Reprogramming Market lineage outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Growing Industry Focus On Cell Reprogramming
4.4.2 Increasing Adoption Of Cell Reprogramming In Cancer Research
4.4.3 Strong Focus Of Key Players On Collaborations And Partnerships To Spur Market Growth
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Ethical Concerns Related To Embryonic Stem Cells
4.5.2 Limited Awareness Regarding Treatment Options To Restrain Market Growth
4.6 Porter’s Five Forces Analysis
4.7 Pipeline Analysis
CHAPTER 5 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Global Cell Reprogramming Market: Technology Movement Analysis
5.2 Sendai Virus-based Reprogramming
5.2.1 Sendai Virus-Based Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 mRNA Reprogramming
5.3.1 mRNA Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Episomal Reprogramming
5.4.1 Episomal Reprogramming Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global Cell Reprogramming Market: Application Movement Analysis
6.2 Research
6.2.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Therapeutic
6.3.1 Therapeutic Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
7.1 Cell Reprogramming Market: End-user Movement Analysis
7.2 Research & Academic Institutes
7.2.1 Research & Academic Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Biotechnology & Pharmaceutical Companies
7.3.1 Biotechnology & Pharmaceutical Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Hospitals & Clinics
7.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 CELL REPROGRAMMING MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Cell Reprogramming Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 India
8.4.5.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.7 Australia
8.4.7.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 ALLELE BIOTECHNOLOGY
9.3.1.1 Company Overview
9.3.1.2 Alere, Inc.
9.3.1.3 Financial Performance
9.3.1.4 Product Benchmarking
9.3.1.5 Strategic Initiatives
9.3.2 ALSTEM
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 APPLIED BIOLOGICAL MATERIALS
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 AXOL BIOSCIENCE
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 CREATIVE BIOARRAY
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 DEFINIGEN
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 FUJIFILM CELLULAR DYNAMICS
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 LONZA
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 MOGRIFY
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 REPROCELL
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 STEMNOVATE
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 THERMO FISHER SCIENTIFIC
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 Regulatory Framework
Table 3 Global cell reprogramming market estimates and forecasts by Technology, 2018 - 2030 (USD Million)
Table 4 Global cell reprogramming market estimates and forecasts by Application, 2018 - 2030 (USD Million)
Table 5 Cell Reprogramming Market - Key Market Restraint
Table 6 Global cell reprogramming sendai virus-based reprogramming market by region, 2018 - 2030 (USD Million)
Table 7 Global cell reprogramming mRNA reprogramming market by region, 2018 - 2030 (USD Million)
Table 8 Global cell reprogramming episomal reprogramming market by region, 2018 - 2030 (USD Million)
Table 9 Global cell reprogramming others market by region, 2018 - 2030 (USD Million)
Table 10 Global cell reprogramming demand in research by region, 2018 - 2030 (USD Million)
Table 11 Global cell reprogramming demand in therapeutic by region, 2018 - 2030 (USD Million)
Table 12 Global cell reprogramming demand in research & academic institutes by region, 2018 - 2030 (USD Million)
Table 13 Global cell reprogramming demand in biotechnology & pharmaceutical companies by region, 2018 - 2030 (USD Million)
Table 14 Global cell reprogramming demand in hospitals & clinics end user by region, 2018 - 2030 (USD Million)
Table 15 North America cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 16 North America cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 17 North America cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 18 U.S. cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 19 U.S. cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 20 U.S. cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 22 Canada cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 23 Canada cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 24 Canada cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 25 Europe cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 26 Europe cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 27 Europe cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 28 Germany cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 29 Germany cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 30 Germany cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 31 U.K. cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 32 U.K. cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 33 U.K. cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 34 France cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 35 France cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 36 France cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 37 Italy cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 38 Italy cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 39 Italy cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 40 Spain cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 41 Spain cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 42 Spain cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 43 Asia Pacific cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 44 Asia Pacific cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 45 Asia Pacific cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 46 China cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 47 China cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 48 China cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 49 India cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 50 India cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 51 India cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 52 Japan cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 53 Japan cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 54 Japan cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 55 South Korea cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 56 South Korea cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 57 South Korea cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 58 Australia cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 59 Australia cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 60 Australia cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 61 Latin America cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 62 Latin America cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 63 Latin America cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 64 Brazil cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 65 Brazil cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 66 Brazil cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 67 Mexico cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 68 Mexico cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 69 Mexico cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 70 MEA cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 71 MEA cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 72 MEA cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 73 South Africa cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 74 South Africa cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 75 South Africa cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 Regulatory Framework
Table 3 Global cell reprogramming market estimates and forecasts by Technology, 2018 - 2030 (USD Million)
Table 4 Global cell reprogramming market estimates and forecasts by Application, 2018 - 2030 (USD Million)
Table 5 Cell Reprogramming Market - Key Market Restraint
Table 6 Global cell reprogramming sendai virus-based reprogramming market by region, 2018 - 2030 (USD Million)
Table 7 Global cell reprogramming mRNA reprogramming market by region, 2018 - 2030 (USD Million)
Table 8 Global cell reprogramming episomal reprogramming market by region, 2018 - 2030 (USD Million)
Table 9 Global cell reprogramming others market by region, 2018 - 2030 (USD Million)
Table 10 Global cell reprogramming demand in research by region, 2018 - 2030 (USD Million)
Table 11 Global cell reprogramming demand in therapeutic by region, 2018 - 2030 (USD Million)
Table 12 Global cell reprogramming demand in research & academic institutes by region, 2018 - 2030 (USD Million)
Table 13 Global cell reprogramming demand in biotechnology & pharmaceutical companies by region, 2018 - 2030 (USD Million)
Table 14 Global cell reprogramming demand in hospitals & clinics end user by region, 2018 - 2030 (USD Million)
Table 15 North America cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 16 North America cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 17 North America cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 18 U.S. cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 19 U.S. cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 20 U.S. cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 22 Canada cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 23 Canada cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 24 Canada cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 25 Europe cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 26 Europe cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 27 Europe cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 28 Germany cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 29 Germany cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 30 Germany cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 31 U.K. cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 32 U.K. cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 33 U.K. cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 34 France cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 35 France cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 36 France cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 37 Italy cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 38 Italy cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 39 Italy cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 40 Spain cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 41 Spain cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 42 Spain cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 43 Asia Pacific cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 44 Asia Pacific cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 45 Asia Pacific cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 46 China cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 47 China cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 48 China cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 49 India cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 50 India cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 51 India cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 52 Japan cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 53 Japan cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 54 Japan cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 55 South Korea cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 56 South Korea cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 57 South Korea cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 58 Australia cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 59 Australia cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 60 Australia cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 61 Latin America cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 62 Latin America cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 63 Latin America cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 64 Brazil cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 65 Brazil cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 66 Brazil cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 67 Mexico cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 68 Mexico cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 69 Mexico cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 70 MEA cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 71 MEA cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 72 MEA cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 73 South Africa cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 74 South Africa cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 75 South Africa cell reprogramming market by end-user, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia cell reprogramming market by technology, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia cell reprogramming market by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia cell reprogramming market by end-user, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Cell reprogramming market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 cell reprogramming market snapshot (2021)
Fig. 8 Market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Consumer behavior analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 Cell reprogramming market technology outlook: Segment dashboard
Fig. 15 Cell reprogramming market: Technology movement analysis
Fig. 16 Sendai virus-based reprogramming market, 2018 - 2030 (USD Million)
Fig. 17 mRNA reprogramming market, 2018 - 2030 (USD Million)
Fig. 18 Episomal reprogramming market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Cell reprogramming market application outlook: Segment dashboard
Fig. 21 Cell reprogramming market: Application movement analysis
Fig. 22 Research market, 2018 - 2030 (USD Million)
Fig. 23 Therapeutic market, 2018 - 2030 (USD Million)
Fig. 24 Cell reprogramming market end-user outlook: Segment dashboard
Fig. 25 Cell reprogramming market: End user movement analysis
Fig. 26 Research & academic institutes market, 2018 - 2030 (USD Million)
Fig. 27 Biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 28 Hospitals & clinics end-users market, 2018 - 2030 (USD Million)
Fig. 29 Regional market: Key takeaways
Fig. 30 Regional outlook, 2021 & 2030
Fig. 31 North America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 33 Canada cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 34 Europe cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 35 U.K. cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 36 Germany cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 37 France cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 38 Italy cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 39 Spain cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 41 Japan cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 42 China cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 43 India cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 44 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 45 Australia cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 46 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 47 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 48 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 49 MEA cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 50 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 51 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 1 Cell reprogramming market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 cell reprogramming market snapshot (2021)
Fig. 8 Market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Consumer behavior analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 Cell reprogramming market technology outlook: Segment dashboard
Fig. 15 Cell reprogramming market: Technology movement analysis
Fig. 16 Sendai virus-based reprogramming market, 2018 - 2030 (USD Million)
Fig. 17 mRNA reprogramming market, 2018 - 2030 (USD Million)
Fig. 18 Episomal reprogramming market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Cell reprogramming market application outlook: Segment dashboard
Fig. 21 Cell reprogramming market: Application movement analysis
Fig. 22 Research market, 2018 - 2030 (USD Million)
Fig. 23 Therapeutic market, 2018 - 2030 (USD Million)
Fig. 24 Cell reprogramming market end-user outlook: Segment dashboard
Fig. 25 Cell reprogramming market: End user movement analysis
Fig. 26 Research & academic institutes market, 2018 - 2030 (USD Million)
Fig. 27 Biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 28 Hospitals & clinics end-users market, 2018 - 2030 (USD Million)
Fig. 29 Regional market: Key takeaways
Fig. 30 Regional outlook, 2021 & 2030
Fig. 31 North America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 33 Canada cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 34 Europe cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 35 U.K. cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 36 Germany cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 37 France cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 38 Italy cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 39 Spain cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 41 Japan cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 42 China cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 43 India cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 44 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 45 Australia cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 46 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 47 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 48 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 49 MEA cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 50 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
Fig. 51 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
